Rational drug repositioning for coronavirus-associated diseases using directional mapping and side-effect inference

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the pathogen of coronavirus disease 2019 (COVID-19), has infected hundreds of millions of people and caused millions of deaths. Looking for valid druggable targets with minimal side effects for the treatment of COVID-19 remains critical....

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jianhua, Liu, Jiaojiao, Luo, Menghan, Cui, Hui, Zhang, Wenwen, Zhao, Ke, Dai, Hongji, Song, Fangfang, Chen, Kexin, Yu, Ying, Zhou, Dongming, Li, Mulin Jun, Yang, Hongxi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9556799/
https://www.ncbi.nlm.nih.gov/pubmed/36267550
http://dx.doi.org/10.1016/j.isci.2022.105348

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9556799/
https://www.ncbi.nlm.nih.gov/pubmed/36267550
http://dx.doi.org/10.1016/j.isci.2022.105348

Ejemplares similares